Rhinitis/rhinorrhea (intranasal products):

Indications for: DYMISTA

Seasonal allergic rhinitis.

Adults and Children:

<6yrs: not established. ≥6yrs: 1 spray per nostril twice daily.

DYMISTA Warnings/Precautions:

Avoid use in recent nasal ulcers, nasal surgery, or nasal trauma. Respiratory tract tuberculosis. Infections (eg, fungal, bacterial, viral, ocular herpes simplex). Avoid exposure to chickenpox and measles; if exposed, consider anti-infective prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with topical corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, lassitude, depression). Monitor growth routinely in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually), and Candida infection or other nasal mucosal changes. History of increased intraocular pressure, glaucoma, and/or cataracts; monitor any change in vision. Avoid eyes. Pregnancy. Nursing mothers: monitor infants.

DYMISTA Classification:

Antihistamine + corticosteroid.

DYMISTA Interactions:

Avoid alcohol or other CNS depressants. Concomitant ritonavir: not recommended. Caution with other potent CYP3A4 inhibitors (eg, ketoconazole).

Adverse Reactions:

Dysgeusia, epistaxis, headache; somnolence, vision changes.

Generic Drug Availability:


How Supplied:

Pump (23g)—120 sprays